Financial Data and Key Metrics Changes - Xylem reported a strong first quarter with total revenues growing by 40% and organic revenues rising by 7%, exceeding guidance [15][23] - Adjusted EBITDA margin increased to 19.2%, up 290 basis points from the prior year, driven by productivity savings and strong volume [15][16] - Earnings per share (EPS) for the quarter was $0.90, reflecting a 14% increase year-over-year [16] Business Line Data and Key Metrics Changes - Measurement & Control Solutions (M&CS) saw organic revenue growth of over 20% with EBITDA margins up 550 basis points year-over-year [9][18] - Water Solutions and Services (WSS) achieved the highest orders growth among all segments, with organic revenue up 6% and pro forma revenue increasing by 9% [21][22] - Water Infrastructure reported a total revenue growth of 40% and organic growth of 6%, driven by robust demand [19] Market Data and Key Metrics Changes - The backlog increased by 4% to $5.3 billion, with organic orders growing by 3% in the quarter [14][15] - Strong demand was noted across developed markets, particularly in the U.S., which experienced double-digit growth [15] Company Strategy and Development Direction - The company is focused on maximizing value from incremental volume and simplifying operations to enhance efficiency [11][12] - Xylem's strategic outlook is supported by secular trends in water security, with increasing demand for solutions that enhance water security [13] - An Investor Day is scheduled for May 30, where updates on strategic outlook and sustainability goals will be shared [14][32] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the operational momentum and resilient demand across most segments, despite monitoring macroeconomic factors like inflation and geopolitical uncertainty [27] - The company is raising its full-year guidance for revenue to approximately $8.5 billion, reflecting an additional point of growth [23][24] Other Important Information - The company is tracking well on cost synergies from the Evoqua acquisition, with expectations of around $100 million in exit rate cost synergies for 2024 [25] - Free cash flow conversion for the year is expected to be 115% of net income [25] Q&A Session Summary Question: Insights on Evoqua integration and revenue synergies - Management highlighted strong momentum in the Evoqua integration, with cost synergies tracking well and revenue synergies ramping up [35][36] Question: Focus on portfolio optimization and M&A opportunities - Management emphasized a focus on executing the platform built over the past decade, with a commitment to driving above-market growth [40][41] Question: Dynamics in orders and market trends - Management noted healthy demand across most end markets, with government funding supporting growth [51][52] Question: Update on IIJA related growth opportunities - Management indicated that government funding will trickle in over the next three to five years, supporting market growth [76] Question: Impact of new EPA rules regarding PFAS - Management stated that compliance timelines for utilities will take time, but Xylem is well-positioned to partner with utilities on PFAS solutions [70] Question: Margin performance in M&CS - Management reported significant margin expansion in M&CS due to productivity and pricing strategies [72][73]

xylem 2024 First Quarter Results & Earnings 0 Forward-Looking Statements This presentation contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Generally, the words "anticipate," "estimate," "expect," "project," "intend," "plan," "contemplate," "predict," "forecast," "likely," "believe," "target," "will," "could," "would," "should," "potential," "may" and similar expressions or t ...

Exhibit 99.1 Xylem Inc. 301 Water Street SE, Suite, 200 Washington, DC 20003 Tel +1.202.869.9150 1 • Orders of $2.2 billion, up 43% on a reported basis and 3% organically • Revenue of $2.0 billion, up 40% on a reported basis and 7% organically • Earnings per share of $0.63, up 17%; $0.90 on an adjusted basis, up 14% • Raising full-year revenue guidance to approximately $8.5B, up 15% to 16%, with organic revenue growth of 4% to 6%, up from 3% to 5% • Lifting full-year adjusted EPS guidance to $4.10 to $4.25, ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 1-35229 Xylem Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) ...

Financial Data and Key Metrics Changes - In Q4 2023, Xylem achieved organic revenue growth of 9%, with full-year organic revenues up 12% and EBITDA margin expansion of 190 basis points [7][8] - Adjusted earnings per share (EPS) grew by 20% for the full year, with Q4 EPS at $0.99, exceeding guidance by $0.03 [13][14] - The company ended the year with a robust financial position, including over $1 billion in cash and a free cash flow conversion of 122% [14] Business Line Data and Key Metrics Changes - Measurement and Control Solutions (M&CS) saw orders growth of 14% and revenue growth of 21%, with improved EBITDA margins of 17.3% [16] - Water Infrastructure reported orders growth of 9% and total revenue growth of 30%, although EBITDA margin was down 90 basis points due to legacy Evoqua impacts [17] - Applied Water experienced flat revenues with a book-to-bill ratio of 0.9, indicating a softer demand environment [18] - Integrated Solutions and Services (ISS) had orders growth of 5% and pro forma revenue growth of 10%, with an adjusted EBITDA margin of 21.1% [19] Market Data and Key Metrics Changes - The backlog across the business grew to $5.1 billion, with organic orders increasing by 10% in Q4 [13] - The U.S. market led growth with double-digit increases across all regions [13] - Demand dynamics in China are being closely monitored, with expectations for flat revenue in 2024 [56] Company Strategy and Development Direction - The company is focused on capturing value from the Evoqua acquisition and enhancing margin expansion through operational excellence and productivity [36][37] - A new Water Solutions and Services segment was created to streamline offerings and enhance recurring revenues [10] - The company aims to simplify water solutions for customers, emphasizing the importance of reducing complexity in water management [30][39] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the resilience of end markets, particularly in utilities and industrial sectors, despite some softness in Applied Water [48][50] - The outlook for 2024 includes organic revenue growth of 3% to 5% and EBITDA margin expansion of 50 to 100 basis points [23] - The company is prepared to take additional cost actions if necessary to maintain margin expansion amid potential volume declines [25] Other Important Information - The company plans to provide recast financial information aligned with the new segment structure later in the month [20] - Xylem's investment thesis remains robust, with a focus on delivering economic and social value through its capabilities [32] Q&A Session Summary Question: What are the top priorities for the company as it starts the year? - The CEO highlighted the importance of capturing value from the Evoqua acquisition, accelerating margin expansion, and scaling the services business enabled by digital solutions [36][37] Question: Can you provide an update on the rollout of the 80/20 initiative and revenue synergy plans for Evoqua? - The CFO mentioned that the 80/20 initiative is a multi-year journey aimed at systematic complexity reduction, with pilots already underway [41] - The CEO noted that regional synergy leads have been appointed to drive revenue capture globally [44] Question: How is the company viewing the CapEx environment in utility and industrial markets? - Management reported strong momentum in CapEx, particularly in the Treatment business, with no signs of pullback in orders [48][49] Question: What are the expectations for pricing in 2024? - The CEO indicated that pricing expectations will ramp down compared to 2023 but will still be higher than pre-pandemic levels [52][53] Question: Can you comment on the situation in China? - The CEO stated that while the backlog is building, revenue conversion has been slow due to funding issues, but the outlook remains flat for 2024 [56] Question: What is the company's approach to M&A in 2024? - The CEO confirmed a strong M&A pipeline with a focus on small to medium bolt-on acquisitions while prioritizing the integration of Evoqua [60]

xylem 2023 Fourth Quarter Results & Earnings 0 Forward-Looking Statements This presentation contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Generally, the words "anticipate," "estimate," "expect," "project," "intend," "plan," "contemplate," "predict," "forecast," "likely," "believe," "target," "will," "could," "would," "should," "potential," "may" and similar expressions or ...

Financial Performance - For the three months ended September 30, 2023, net income was $152 million, a significant increase from $12 million in the same period of 2022, representing a 1,167% growth[10]. - For the nine months ended September 30, 2023, net income reached $343 million, compared to $206 million in 2022, marking a 66% increase[10]. - The company reported comprehensive income of $78 million for the three months ended September 30, 2023, compared to $61 million in the same period of 2022, an increase of 28%[10]. - Revenue for the three months ended September 30, 2023, was $2,076 million, a 50% increase from $1,380 million in the same period of 2022[38]. - Total revenue for the three months ended September 30, 2023, was $1,950 million, a 47.7% increase from $1,319 million in the same period of 2022[40]. - Operating income for Q3 2023 was $191 million, up 13.7% from $168 million in Q3 2022[130]. - The net income for the three months ended September 30, 2023, was $180 million, significantly higher than the $28 million reported for the same period in 2022[34]. - The total operating income for the nine months ended September 30, 2023, was $441 million, compared to $425 million for the same period in 2022[130]. Assets and Liabilities - Total assets as of September 30, 2023, were $15,905 million, up from $7,952 million at the end of 2022, indicating a 99% growth[12]. - Long-term debt increased to $2,253 million as of September 30, 2023, from $1,880 million at the end of 2022, a growth of 20%[12]. - As of September 30, 2023, total debt outstanding is $2,270 million, an increase from $1,880 million as of December 31, 2022, representing a 20.7% increase[77]. - Total accrued and other current liabilities increased to $1,160 million as of September 30, 2023, compared to $867 million as of December 31, 2022, reflecting a 33.7% increase[75]. - The fair value of Senior Notes due 2026 was $466 million as of September 30, 2023, down from $470 million as of December 31, 2022[82]. - The fair value of Senior Notes due 2046 was $303 million as of September 30, 2023, down from $333 million at the end of 2022[82]. Cash Flow and Expenditures - Operating cash flow for the nine months ended September 30, 2023, was $382 million, compared to $234 million in 2022, reflecting a 63% increase[13]. - Capital expenditures for the nine months ended September 30, 2023, were $177 million, up from $148 million in 2022, a rise of 20%[13]. - Cash and cash equivalents decreased to $705 million as of September 30, 2023, from $944 million at the end of 2022, a decline of 25%[12]. - The company reported a net cash provided by operating activities of $382 million for the nine months ended September 30, 2023, compared to $234 million in 2022[13]. Acquisitions and Business Segments - The acquisition of Evoqua Water Technologies Corp. was completed on May 24, 2023, enhancing the company's service revenue definition to include outsourced water services and SaaS subscriptions[17][22]. - The acquisition of Evoqua Water Technologies Corp. was completed on May 24, 2023, for a total consideration of $6,900 million, including $6,121 million in Xylem common stock[24][26]. - Evoqua generated revenue of $540 million and a loss before taxes of $14 million for the three months ended September 30, 2023[29]. - The Water Infrastructure segment includes Applied Product Technologies from the Evoqua acquisition, focusing on water treatment and transportation solutions[128]. - The Applied Water segment serves residential, commercial, and industrial markets with major products including pumps and valves[128]. - The Measurement & Control Solutions segment develops advanced technology solutions for water and energy conservation[128]. - The Integrated Solutions and Services segment offers tailored services and solutions, including outsourced water and emergency response services[128]. Stock and Shareholder Information - Basic earnings per share for the three months ended September 30, 2023, was $0.63, up from $0.07 in the same period of 2022, while diluted earnings per share also increased to $0.63 from $0.07[55]. - The company declared dividends of $0.33 per share, totaling $80 million for the nine months ended September 30, 2023[102]. - The total stockholders' equity increased to $9.941 billion as of September 30, 2023, from $3.226 billion at the beginning of 2022[102][103]. - The company repurchased approximately 0.1 million shares for $10 million during the nine months ended September 30, 2023[114]. - The company has up to $182 million remaining for share repurchases under its existing program as of September 30, 2023[114]. Restructuring and Impairment - The company recognized $20 million in restructuring costs for Q3 2023, significantly higher than $3 million in Q3 2022, primarily due to the acquisition of Evoqua[44]. - Total expected restructuring costs for actions commenced in 2023 are projected to be $62 million, with $20 million already incurred by Q3 2023[48]. - The company recognized an impairment charge of $2 million for in-process software during Q1 2023, indicating a strategic shift in investment priorities[60]. - The company recognized a $1 million impairment charge for fixed assets in the Measurement & Control Solutions segment during Q3 2023[49]. Tax and Compliance - The effective tax rate for Q3 2023 was 17.8%, down from 27.8% in Q3 2022, with a tax provision of $33 million[53]. - The company has no unrecognized tax benefits related to uncertain tax positions as of September 30, 2023[54]. - The company is in compliance with all covenants for the Green Bond as of September 30, 2023[80]. Legal and Environmental Matters - The company is involved in various legal proceedings related to environmental, tax, and product liability matters, but does not expect a material adverse effect on operations[121]. - The company has received notifications from environmental agencies regarding sites requiring investigation and remediation, with liabilities considered de minimis in many cases[123]. - The company has estimated and accrued $4 million for environmental matters as of September 30, 2023, consistent with the amount accrued as of December 31, 2022[124].

Financial Data and Key Metrics Changes - Total revenues grew 50%, with organic revenue rising 10%, driven by strong performance across segments [18][20] - EBITDA margin expanded to 19.8%, up 150 basis points year-over-year, attributed to higher volumes and productivity savings [20] - Earnings per share (EPS) for the quarter was $0.99, reflecting a 14% year-over-year growth [10][20] - The total backlog increased to $5.2 billion, up 5% organically, indicating strong demand [10][20] Business Line Data and Key Metrics Changes - **M&CS Segment**: Revenue increased by 25%, with a backlog of $2.3 billion, up 11% organically [21][20] - **Water Infrastructure Segment**: Reported growth of 40% and organic growth of 7%, driven by strong price realization [23][20] - **Applied Water Segment**: Revenues grew 1%, with a modest increase in orders by 2% [25][20] - **Integrated Solutions & Services (ISS)**: Revenue grew 10% year-over-year, with a backlog exceeding $1 billion, up 14% [27][20] Market Data and Key Metrics Changes - Utilities market grew 16%, driven by demand and price realization [19][20] - Industrial market grew 5%, supported by strong demand in the U.S. and Western Europe [19][20] - Emerging markets saw a decline, particularly in China, despite strengths in other regions [18][20] Company Strategy and Development Direction - The integration of Evoqua is on track to deliver promised cost and growth synergies, enhancing the company's capabilities [11][40] - The company aims to deepen penetration in utilities and expand its presence in industrial verticals, leveraging combined offerings [41][42] - A focus on optimizing the portfolio for growth and simplifying access to solutions for customers is emphasized [44] Management's Comments on Operating Environment and Future Outlook - Management remains optimistic about demand resilience in utilities and steady growth in industrial markets, despite some regional softness [46][49] - The company anticipates mid-teens growth in utilities and high single-digit growth in industrial markets for the upcoming year [47][49] - Concerns exist regarding emerging markets, particularly China, where utility demand has been weaker [92][93] Other Important Information - The company is committed to achieving free cash flow conversion above 100% of net income [56] - The new CFO, Bill Grogan, has taken over, with a focus on driving operational efficiency and value creation [52][56] Q&A Session Summary Question: Update on Evoqua's revenue synergies and customer opportunities - Management highlighted strong momentum in revenue synergies, with successful integration of Evoqua's products into existing offerings and early wins in cross-selling [70][75] Question: Insights on M&CS order trends and chip supply - Orders were down due to timing issues, but backlog remains strong, with gradual improvement in chip supply expected to continue [80][82] Question: Outlook for end markets heading into 2024 - Management expressed optimism about utilities and industrial markets, while noting potential concerns in applied water and emerging markets [88][92] Question: Pricing and cost dynamics moving forward - Positive price-cost dynamics were noted, with expectations for pricing to moderate in 2024 as previous increases are lapped [94][95] Question: Integration of R&D efforts between Evoqua and Xylem - Management confirmed synergies in R&D, particularly in areas like PFAS, with efforts to eliminate duplication and enhance innovation [106][108]

2023 Third Quarter Results & Earnings Forward-Looking Statements This presentation contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Generally, the words "anticipate," "estimate," "expect," "project," "intend," "plan," "contemplate," "predict," "forecast," "likely," "believe," "target," "will," "could," "would," "should," "potential," "may" and similar expressions or their neg ...

Second Quarter 2023 Earnings May 2, 2023 Forward-Looking Statement Safe Harbor and non-GAAP Financial Information This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. You can generally identify forward-looking statements by our use of forward-looking terminology such a ...